Abivax S.A. Liabilities Arising From Financing Activities
Abivax S.A. (ABVX) had Liabilities Arising From Financing Activities of EUR 32.09 million as of 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Notes
ifrs-full:LiabilitiesArisingFromFinancingActivities · last filed 2026-03-23
- 2025-12-31: Liabilities Arising From Financing Activities 32.09M EUR.
- 2025-09-30: Liabilities Arising From Financing Activities 73.99M EUR.
- 2025-06-30: Liabilities Arising From Financing Activities 98.71M EUR.
- 2025-03-31: Liabilities Arising From Financing Activities 106.56M EUR.
| Period end | Liabilities Arising From Financing Activities |
|---|---|
| 2025-12-31 | 32.09M EUR 20-F · filed 2026-03-23 |
| 2025-09-30 | 73.99M EUR 6-K · filed 2025-12-15 |
| 2025-06-30 | 98.71M EUR 6-K · filed 2025-09-08 |
| 2025-03-31 | 106.56M EUR 6-K · filed 2025-06-02 |
| 2024-12-31 | 109.22M EUR 20-F · filed 2026-03-23 |
| 2024-09-30 | 113.99M EUR 6-K · filed 2025-12-15 |
| 2024-06-30 | 113.36M EUR 6-K · filed 2025-09-08 |
| 2024-03-31 | 96.11M EUR 6-K · filed 2025-06-02 |
| 2023-12-31 | 74.47M EUR 20-F · filed 2026-03-23 |
| 2022-12-31 | 49.23M EUR 20-F · filed 2026-03-23 |
| 2021-12-31 | 51.65M EUR 20-F · filed 2025-03-24 |
| 2020-12-31 | 42.45M EUR 20-F · filed 2024-04-05 |